1-2 of 2
William Pullman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Alternative Pathway Masp-3 Inhibitor OMS906 in a Phase 1 Study of Healthy Subjects

William Pullman, Jane Humphreys, Edward Philpot, W. Jason Cummings
Journal: Blood
Blood (2022) 140 (Supplement 1): 5801–5802.
https://doi.org/10.1182/blood-2022-162828
Published: 2022
Journal Articles

Trial in Progress: An Open-Label, Multi-Center Phase 2 Study Evaluating Efficacy and Safety of the Masp-2 Inhibitor Narsoplimab in Pediatric Patients with High-Risk Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA)

William Pullman, Mary Brough, Carolina Soto, Tze-Chiang Meng
Journal: Blood
Blood (2022) 140 (Supplement 1): 8493–8494.
https://doi.org/10.1182/blood-2022-155820
Published: 2022